All In MedTech

FDA Clearance Tracker · P170007

DUROLANE

Premarket approval (PMA) is the pathway for the highest-risk devices. FDA reviews clinical evidence of safety and effectiveness before approving.

Last checked: Nov 20, 2026Latest source record: Aug 29, 2017 (this decision)Source: openFDAMethods & limitations

PMA

Decided

Aug 29, 2017

Approved

Time to decision

180 days

Received Mar 2, 2017. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA

Device class

Class III

The decision

FDA number
P170007
Device name
DUROLANE
Applicant location
Durham, NC
Received
Mar 2, 2017
Decided
Aug 29, 2017
Decision
Approved
Supplements
15 in FDA's data for this PMA. See them on the FDA record

Device type

Device class
Class III

Every decision under product code MOZ

FDA's approval statement

As written in FDA's record.

APPROVAL FOR DUROLANE. THIS DEVICE IS INDICATED FOR THE TREATMENT OF PAIN IN OSTEOARTHRITIS OF THE KNEE IN PATIENTS WHO HAVE FAILED TO RESPOND ADEQUATELY TO CONSERVATIVE NON-PHARMACOLOGICAL THERAPY OR SIMPLE ANALGESICS, E.G., ACETAMINOPHEN.

How new is this?

These are facts about FDA's records. They are not a judgment about the device.

  • It is not the first decision under product code MOZ. The earliest in FDA's data is P950027, decided May 28, 1997.
  • It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.

Source documents

Other decisions for Bioventus, LLC

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

3 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.